Detalles de la búsqueda
1.
A Phase 1/2A trial of idroxioleic acid: first-in-class sphingolipid regulator and glioma cell autophagy inducer with antitumor activity in refractory glioma.
Br J Cancer
; 129(5): 811-818, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37488446
2.
Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer.
Br J Cancer
; 114(7): 723-30, 2016 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-27002934
3.
Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer.
Br J Cancer
; 114(12): e21, 2016 06 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-27228289
4.
Two minor NQO1 and NQO2 alleles predict poor response of breast cancer patients to adjuvant doxorubicin and cyclophosphamide therapy.
Pharmacogenet Genomics
; 21(12): 808-19, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21946896
5.
Pharmacokinetics and Pharmacogenetics of Cyclophosphamide in a Neonate and Infant Childhood Cancer Patient Population.
Pharmaceuticals (Basel)
; 14(3)2021 Mar 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33809608
6.
Phase I study of MG98, an oligonucleotide antisense inhibitor of human DNA methyltransferase 1, given as a 7-day infusion in patients with advanced solid tumors.
Clin Cancer Res
; 15(9): 3177-83, 2009 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19383817
7.
Pharmacokinetic investigation of imatinib using accelerator mass spectrometry in patients with chronic myeloid leukemia.
Clin Cancer Res
; 13(14): 4164-9, 2007 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17634544
8.
Development and validation of a LC-MS/MS method for the quantification of the checkpoint kinase 1 inhibitor SRA737 in human plasma.
Bioanalysis
; 9(13): 1001-1010, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28692309
9.
Pharmacogenetic association of MBL2 and CD95 polymorphisms with grade 3 infection following adjuvant therapy for breast cancer with doxorubicin and cyclophosphamide.
Eur J Cancer
; 71: 15-24, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27940354
10.
A phase I and pharmacokinetic study of paclitaxel poliglumex (XYOTAX), investigating both 3-weekly and 2-weekly schedules.
Clin Cancer Res
; 11(21): 7834-40, 2005 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16278406
11.
Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma.
Eur J Cancer
; 55: 56-64, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26773420
12.
A phase I pharmacokinetic and pharmacodynamic study of the oral mitogen-activated protein kinase kinase (MEK) inhibitor, WX-554, in patients with advanced solid tumours.
Eur J Cancer
; 68: 1-10, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27693888
13.
Efficacy of PARP Inhibitor Rucaparib in Orthotopic Glioblastoma Xenografts Is Limited by Ineffective Drug Penetration into the Central Nervous System.
Mol Cancer Ther
; 14(12): 2735-43, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26438157
14.
Determination of anti-cancer drug actinomycin D in human plasma by liquid chromatography-mass spectrometry.
J Chromatogr B Analyt Technol Biomed Life Sci
; 795(2): 237-43, 2003 Oct 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-14522028
Resultados
1 -
14
de 14
1
Próxima >
>>